Conference Coverage (Montreal)

Crosslinked Hemoglobin Improves Perfusion Due to Increased RBC Velocity

Published in Blood Weekly, September 30th, 1996

A cross-linked hemoglobin product was reported to increase cerebral and renal blood perfusion after hemorrhage.

This significant increase of blood perfusion might contribute toward its efficacy as a resuscitative agent, indicated Ashok Kumar, University of Illinois at Chicago, Chicago, Illinois, and colleagues at the VI International Symposium on Blood Substitutes, held August 5-7, 1996, at McGill University, in Montreal, Quebec, Canada.

The researchers said the purpose of the study was to determine the effect of diaspirin crosslinked hemoglobin (DCLHb; a hemoglobin-based blood substitute developed by Baxter Healthcare Corporation) on microvascular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1996-09-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry